BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 94 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $177,000 | -59.3% | 168,203 | -34.2% | 0.07% | -59.6% |
| Q2 2019 | $435,000 | +2.4% | 255,703 | +102.7% | 0.18% | +8.3% |
| Q1 2019 | $425,000 | +30.8% | 126,127 | +13.2% | 0.17% | +10.5% |
| Q4 2018 | $325,000 | -41.5% | 111,427 | +23.4% | 0.15% | -15.0% |
| Q3 2018 | $556,000 | -1.8% | 90,327 | +17.8% | 0.18% | -15.1% |
| Q2 2018 | $566,000 | +27.5% | 76,653 | +13.3% | 0.21% | +15.8% |
| Q1 2018 | $444,000 | -11.9% | 67,653 | +12.8% | 0.18% | -8.5% |
| Q4 2017 | $504,000 | -23.4% | 59,984 | +5.3% | 0.20% | -28.8% |
| Q3 2017 | $658,000 | +182.4% | 56,984 | +185.1% | 0.28% | +189.7% |
| Q2 2017 | $233,000 | +77.9% | 19,984 | +88.8% | 0.10% | +54.0% |
| Q1 2017 | $131,000 | – | 10,584 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 15,086 | $306,000 | 0.84% |
| Baker Brothers Advisors | 4,865,647 | $98,627,000 | 0.82% |
| Cormorant Asset Management, LP | 300,000 | $6,081,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,515 | $4,693,000 | 0.69% |
| QVT Financial LP | 340,986 | $6,912,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 87,000 | $1,763,000 | 0.29% |
| Hatteras Investment Partners, LP | 10,410 | $211,000 | 0.28% |
| MCDANIEL TERRY & CO | 33,836 | $686,000 | 0.18% |
| Highlander Capital Management, LLC | 6,500 | $132,000 | 0.12% |
| EverPoint Asset Management, LLC | 265,000 | $5,372,000 | 0.11% |